David Aaron Hendricks, RN in Ardmore, AL - Registered Nurse

David Aaron Hendricks, RN is a Registered Nurse based in Ardmore, Alabama. David Aaron Hendricks is licensed to practice in Alabama (license number 1-173440) and his current practice location is 28868 Oak Grove Rd, Ardmore, Alabama. He can be reached at his office (for appointments etc.) via phone at (256) 656-7072.

NPI number for David Aaron Hendricks is 1548906829 and his current mailing address is 28868 Oak Grove Rd, Ardmore, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1548906829.

Contact Information

	David Aaron Hendricks, RN
	28868 Oak Grove Rd, Ardmore, AL 35739-7526
	(256) 656-7072
	Not Available

Provider's Profile

Full Name	David Aaron Hendricks
Gender	Male
Speciality	Registered Nurse
Location	28868 Oak Grove Rd, Ardmore, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1548906829
Provider Enumeration Date: 05/09/2022
Last Update Date: 05/09/2022

Medical Identifiers

Medical identifiers for David Aaron Hendricks such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548906829	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
163W00000X	Registered Nurse	1-173440 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Aaron Hendricks is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Aaron Hendricks, RN 28868 Oak Grove Rd, Ardmore, AL 35739-7526 Ph: (256) 656-7072	David Aaron Hendricks, RN 28868 Oak Grove Rd, Ardmore, AL 35739-7526 Ph: (256) 656-7072

News Archive

First patient enrolled in Contravir‘s FV-100 Phase 3 study to prevent shingles, shingles-associated pain

ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the first patient has been enrolled in the Company's pivotal Phase 3 clinical study, study 007, of FV-100 to prevent the debilitating shingles-associated pain known as post-herpetic neuralgia (PHN).

Majority of Medicaid patients on antipsychotic drugs do not undergo metabolic tests, says study

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Research reveals significant role of Axl receptor in progression, therapeutic resistance of AML

BerGenBio AS, an oncology biopharmaceutical company, announces that a paper entitled "Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine cross-talk of leukemia cells with bone marrow stroma" by Ben-Batalla et al., has been published in Blood, the most cited peer-reviewed research journal in the field of hematology.

Study shows decreasing telomere length may contribute to onset of age-related diseases

Mouse models of human disease have made it possible to gain important insights into many conditions. However, many diseases remain for which no mouse model exists, and large proportion of human diseases without mouse models are associated with aging.

Lhasa purchases Granary Wharf House for new international Headquarters

Lhasa Limited, a leading global supplier of knowledge-based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the purchase of Granary Wharf House, Leeds, as its new international Headquarters.

David Aaron Hendricks, RN - Registered Nurse in Ardmore, AL